Episode

MSL vs. MOL - ALL You Need to Know

Podcast
MSL Talk
Published
Dec 16, 2025
Duration seconds
2140
Processing state
not_requested
Canonical source
https://msltalk.carolangroup.com/episodes/S1CvuHY6Q8Z
Audio
https://media.podcastai.com/episodes/S1CvuHY6Q8Z.mp3?u=1765883701
JSON
/v1/public/podcasts/msl-talk-274943/episodes/msl-vs-mol-all-you-need-to-know
Markdown
/podcast/msl-talk-274943/msl-vs-mol-all-you-need-to-know.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/msl-talk-274943/episodes/msl-vs-mol-all-you-need-to-know/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/msl-talk-274943/msl-vs-mol-all-you-need-to-know.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, Tom Caravela is joined by Mahesh Tawney to explore the evolving role of Medical Outcomes Liaisons (MOLs). They delve into the distinctions between MSL and MOL positions, highlighting the unique value narrative MOLs bring to the table. The discussion covers collaboration with market access and reimbursement specialists, as well as the metrics used to gauge MOL success. Tom and Mahesh emphasize effective communication strategies and the importance of both IQ and EQ in liaison roles. The conversation also touches on the collaborative mindset necessary for MSLs, strategies for transitioning from MSL to MOL, and networking. The episode concludes with insights into the future of MOL roles.